Rosangela Lattanzio Selected Research

Rosangela Lattanzio Research Topics

22	Macular Edema 04/2024 - 01/2007
12	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2023 - 01/2007
10	Retinal Vein Occlusion 06/2023 - 01/2013
3	Type 2 Diabetes Mellitus (MODY) 04/2020 - 07/2011
2	Cataract (Cataracts) 03/2024 - 10/2020
2	Inflammation (Inflammations) 01/2021 - 12/2020
2	Macular Degeneration (Age-Related Maculopathy) 01/2017 - 01/2007
2	Ischemia 11/2014 - 05/2014
1	Rare Diseases (Rare Disease) 10/2022
1	Epiretinal Membrane (Epiretinal Membranes) 04/2022
1	Ocular Hypertension (Glaucoma, Suspect) 01/2021
1	Optic Disk Drusen (Optic Disc Drusen) 01/2020
1	Arteriovenous Malformations (Arteriovenous Malformation) 01/2020
1	Embolism (Embolus) 03/2017
1	Blindness (Hysterical Blindness) 03/2017
1	Glaucoma 01/2017
1	Choroidal Neovascularization 05/2015
1	Retinoschisis (Retinoschisis, Juvenile) 11/2014
1	Edema (Dropsy) 05/2014
1	Retinal Perforations 02/2013
1	Diabetes Mellitus 02/2013
1	Hypoxia (Hypoxemia) 09/2012
1	Cavernous Hemangioma (Cavernous Angioma) 01/2012
1	Neoplasms (Cancer) 01/2012
1	Telangiectasis (Telangiectasia) 01/2012
1	Capillary Hemangioma 01/2012
1	Microaneurysm 01/2012
1	Retinal Telangiectasis 01/2012
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2011
1	Disease Progression 01/2011
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2007
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2007

16	Retinaldehyde (Retinal)IBA 04/2024 - 07/2011
9	Dexamethasone (Maxidex)FDA LinkGeneric 10/2020 - 01/2012
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2020 - 01/2007
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2012
4	Fluocinolone Acetonide (Capex)FDA LinkGeneric 02/2024 - 01/2020
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 01/2011
2	SteroidsIBA 01/2017 - 01/2014
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	Endothelial Growth FactorsIBA 01/2020
1	Neuroprotective AgentsIBA 01/2019
1	Brimonidine Tartrate (Alphagan)FDA LinkGeneric 01/2019
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2019
1	Ranibizumab (Lucentis)FDA Link 07/2015
1	Chromogranin AIBA 05/2015
1	vasostatin IIBA 05/2015
1	Fluorescein (Funduscein)FDA LinkGeneric 05/2014
1	SmokeIBA 05/2014
1	erucylphosphocholineIBA 04/2012

5	Therapeutics 03/2024 - 01/2012
3	Lasers (Laser) 01/2017 - 02/2013
1	Intravitreal Injections 01/2023
1	Vitrectomy 04/2022
1	Injections 01/2020
1	Topical Administration 01/2019
1	Cardiac Resynchronization Therapy Devices 03/2017
1	Cardiac Resynchronization Therapy 03/2017
1	Contraindications 01/2017
1	Retreatment 06/2015
1	Slit Lamp 05/2014
1	Vitreoretinal Surgery 02/2013
1	Light Coagulation 02/2013